FORT LAUDERDALE, Fla., Nov. 29, 2016 (GLOBE NEWSWIRE) -- OmniComm Systems, Inc. (OTCQX:OMCM) received the highest grades for electronic data capture (EDC) software from clinical trial researchers, according to a survey of more than 430 site researchers from around the globe. Porter Research, an independent firm based in Atlanta, recently surveyed clinical research site investigators and staff from more than 390 sites in 30 countries to measure degrees of satisfaction and preference of EDC systems. As part of the survey, site investigators selected their top choice for EDC system based on actual experience and EDC usage during clinical trials over the last two years. Additionally, survey participants rated EDC systems based on ease of use, performance and customer support. OmniComm's TrialMaster ® EDC was the only EDC system that exceeded the average in each category.
Ease of Use
OmniComm TrialMaster EDC
Other EDC Systems
Moreover, based upon OmniComm's research reflecting the last two years of EDC usage, it has become clear that OmniComm is now the third-largest EDC company, as measured by the number of studies, with an 8% market share after Medidata (38%) and Oracle (InForm - 20% and Oracle Clinical & Remote Data Capture - 15%).